Literature DB >> 10413329

Case-control studies using only malformed infants: are we interpreting the results correctly?

L Prieto, M L Martínez-Frías.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10413329     DOI: 10.1002/(SICI)1096-9926(199907)60:1<1::AID-TERA1>3.0.CO;2-9

Source DB:  PubMed          Journal:  Teratology        ISSN: 0040-3709


× No keyword cloud information.
  5 in total

1.  Response to: Case-control studies require appropriate population controls: an example of error in the SSRI birth defect literature.

Authors:  Helen Dolk; Anthony Wemakor
Journal:  Eur J Epidemiol       Date:  2015-11-30       Impact factor: 8.082

Review 2.  Postmarketing analysis of medicines: methodology and value of the spanish case-control study and surveillance system in preventing birth defects.

Authors:  María Luisa Martínez-Frías
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

3.  Risk of hypospadias in newborn infants exposed to valproic acid during the first trimester of pregnancy: a case-control study in Spain.

Authors:  Elvira Rodríguez-Pinilla; Consuelo Mejías; David Prieto-Merino; Paloma Fernández; María L Martínez-Frías
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

4.  Methodological approaches to evaluate teratogenic risk using birth defect registries: advantages and disadvantages.

Authors:  Fernando A Poletta; Jorge S López Camelo; Juan A Gili; Emmanuele Leoncini; Eduardo E Castilla; Pierpaolo Mastroiacovo
Journal:  PLoS One       Date:  2012-10-03       Impact factor: 3.240

5.  Metformin exposure in first trimester of pregnancy and risk of all or specific congenital anomalies: exploratory case-control study.

Authors:  Joanne E Given; Maria Loane; Ester Garne; Marie-Claude Addor; Marian Bakker; Bénédicte Bertaut-Nativel; Miriam Gatt; Kari Klungsoyr; Nathalie Lelong; Margery Morgan; Amanda J Neville; Anna Pierini; Anke Rissmann; Helen Dolk
Journal:  BMJ       Date:  2018-06-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.